Full-Time

Sr. Scientist

Biomarker Assay Development

Confirmed live in the last 24 hours

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$108.6k - $157.3kAnnually

+ Annual Bonus + Equity Incentive Program

Senior

San Diego, CA, USA

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis

You match the following Neurocrine Biosciences's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • BS/BA degree and 5+ years of relevant experience, OR
  • MS/MA degree and 3+ years of relevant experience OR
  • PhD or equivalent and some relevant experience; may include postdoc experience.
  • Track record of successful implementation of immunoassays, proteomics, and cell-based assays (e.g., flow cytometry) for biomarker discovery using pre-clinical or clinical samples
  • Extensive experience working with tissue samples and/or biofluids
  • Experience with some of these techniques: ELISA, IP, western blotting, flow cytometry, high content imaging, HTRF
  • Experience with managing contract research organizations
  • Hands-on experience with the pros and cons of different biomarker assay platforms (eg. Luminex, MesoScale Discovery and/or SIMOA) is preferred.
  • Exosome purification in humans and non-clinical species is a plus
  • Experience working with human biospecimens is a plus
  • Demonstrates solid level of understanding project / group goals and methods
  • Consistently recognizes anomalous and inconsistent results and interprets experimental outcomes
  • Able to explain the process behind the data and implications of the results
  • Strong knowledge of one or more scientific disciplines, becoming expert in one discipline
  • Strong knowledge of scientific principles, methods and techniques
  • Strong knowledge and demonstrated ability working with a variety of laboratory equipment/tools
  • Ability to work as part of a team; may train lower levels
  • Excellent computer skills
  • Strong communications, problem-solving, analytical thinking skills
  • Detail-oriented yet can see broader picture of scientific impact on team
  • Ability to meet multiple deadlines, with a high degree of accuracy and efficiency
  • Strong project management skills
Responsibilities
  • Designs, develops, and performs robust "fit-for-purpose" clinical biomarker assays
  • Identifies and evaluates new technologies to support evolving translational biomarker strategies
  • Capacity to perform lab work independently and direct the outsourcing of studies to CROs.
  • Assists in the transition of biomarker assays from Basic Research to Clinical use by providing technical guidance on assay validation.
  • Serves as a subject matter expert in immunoassay-based assay development and validation, collaborating with project teams, biomarker leaders, clinical operations and regulatory affairs on the implementation of these assays in clinical trials.
  • Collaborates with external academic and industry experts to expand Neurocrine’s knowledge base in biofluid biomarkers
  • Generates and works with complex data sets, with a strong understanding of advanced data analysis and statistical tests
  • Maintains and updates SOPs and writes data summaries for experiments conducted.
  • Reviews, comprehends, and complies with all SOP’s, and safety and quality assurance standards at all times.
  • Provides training and/or supervision to junior staff, as needed.
  • Other duties as assigned.
Desired Qualifications
  • Hands-on experience with the pros and cons of different biomarker assay platforms (eg. Luminex, MesoScale Discovery and/or SIMOA) is preferred.
  • Exosome purification in humans and non-clinical species is a plus
  • Experience working with human biospecimens is a plus
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

1992

Simplify Jobs

Simplify's Take

What believers are saying

  • CRENESSITY's FDA approval marks a significant advancement in CAH treatment.
  • Collaboration with Nxera Pharma strengthens Neurocrine's position in neuropsychiatric therapeutics.
  • Participation in major healthcare conferences boosts Neurocrine's visibility and investor relations.

What critics are saying

  • Increased competition in muscarinic agonist market may impact Neurocrine's market share.
  • Reliance on PANTHERx Rare for distribution poses potential partnership risks.
  • High cost of CRENESSITY could limit patient accessibility and market penetration.

What makes Neurocrine Biosciences unique

  • CRENESSITY is the first non-steroidal treatment for classic congenital adrenal hyperplasia.
  • Neurocrine's muscarinic agonist portfolio targets innovative treatments for neuropsychiatric disorders.
  • Partnership with Pantherx® Rare enhances patient access to rare disease treatments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Parental Leave

Health Insurance

Dental Insurance

Vision Insurance

Paid Holidays